[Cytokines Summit 2022] Enabling Cytokine Therapeutic Development with Qualified, Functional Cell-Based Assays

[Cytokines Summit 2022] Enabling Cytokine Therapeutic Development with Qualified, Functional Cell-Based Assays
File Name/Number:
Cytokines Summit

Year:
2022

 

Gaurav Agrawal, Ph.D.Scientific Development Manager

 
  • Discover how cell-based assays and translational services accelerate cytokine-based immunotherapeutic development from early discovery to GMP Lot Release Testing
  • Learn about industry’s largest cell-based assay portfolio covering 80+ cytokine, interleukin and chemokine targets including IL-1, IL-2, IL-6, IL-7, IL-12, IL-15, IL-17, GM-CSF, CCRs, and CXCRs
  • Delve into custom bioassay qualification case studies showing development of fit-for-purpose bioassays for potency, stability, and NAb testing
  • Learn how method transfer support is critical for assay implementation at CRO sites
  • Gain human insights early, with custom biomarker services and the BioMAP® Platform of cell-based disease models